Australia markets close in 5 hours 45 minutes

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
7.82-0.27 (-3.34%)
At close: 04:00PM EDT
7.90 +0.08 (+1.02%)
After hours: 07:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.85B
Enterprise value 24.30B
Trailing P/E N/A
Forward P/E 2.13
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.32
Price/book (mrq)N/A
Enterprise value/revenue 2.71
Enterprise value/EBITDA 11.40

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 335.06%
S&P500 52-week change 322.38%
52-week high 311.46
52-week low 35.57
50-day moving average 39.27
200-day moving average 38.30

Share statistics

Avg vol (3-month) 32.95M
Avg vol (10-day) 32.95M
Shares outstanding 5366.8M
Implied shares outstanding 6377.53M
Float 8307.07M
% held by insiders 10.91%
% held by institutions 178.97%
Shares short (15 Apr 2024) 420.71M
Short ratio (15 Apr 2024) 45.48
Short % of float (15 Apr 2024) 47.49%
Short % of shares outstanding (15 Apr 2024) 45.65%
Shares short (prior month 15 Mar 2024) 423.78M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 46.52
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 410 Nov 2010
Last split factor 22:1
Last split date 316 Oct 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -5.07%
Operating margin (ttm)13.89%

Management effectiveness

Return on assets (ttm)4.04%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)8.97B
Revenue per share (ttm)24.51
Quarterly revenue growth (yoy)10.80%
Gross profit (ttm)N/A
EBITDA 2.96B
Net income avi to common (ttm)-455M
Diluted EPS (ttm)-1.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)733M
Total cash per share (mrq)2
Total debt (mrq)22.07B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.23
Book value per share (mrq)-3.04

Cash flow statement

Operating cash flow (ttm)1.09B
Levered free cash flow (ttm)797.12M